A Path Forward in Managing AML - NEW VIRTUAL EVENT - 10/1/24

Sep 24, 2024
1 min read

Recent Posts

See All

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

Management of high-risk non-melanoma skin cancers (NMSC)

Dear BONS Membes, I’d like to invite you to join a Dana-Farber–anchored, multidisciplinary CME activity focused on the management of high-risk non-melanoma skin cancers (NMSC)—including BCC, cSCC, and

Comments